S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Shift in war's front seen as ships cleared to leave Ukraine
Dems' climate, energy, tax bill clears initial Senate hurdle
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Shift in war's front seen as ships cleared to leave Ukraine
Dems' climate, energy, tax bill clears initial Senate hurdle
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Shift in war's front seen as ships cleared to leave Ukraine
Dems' climate, energy, tax bill clears initial Senate hurdle
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Demand for grocery delivery cools as food costs rise
Musk says Twitter deal could move ahead with 'bot' info
Shift in war's front seen as ships cleared to leave Ukraine
Dems' climate, energy, tax bill clears initial Senate hurdle
Dems push Biden climate, health priorities toward Senate OK
Transit woes mount for Boston's beleaguered subway riders
NASDAQ:PRPO

Precipio (PRPO) Stock Forecast, Price & News

$1.60
+0.07 (+4.58%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.40
$1.63
50-Day Range
$1.06
$1.60
52-Week Range
$0.91
$4.17
Volume
309,049 shs
Average Volume
277,737 shs
Market Capitalization
$36.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Precipio MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.57% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.99mentions of Precipio in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.39 out of 5 stars

Medical Sector

1101st out of 1,283 stocks

Analytical Instruments Industry

28th out of 35 stocks

Precipio logo

About Precipio (NASDAQ:PRPO) Stock

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

Precipio Stock Performance

NASDAQ:PRPO opened at $1.60 on Friday. The company has a current ratio of 2.59, a quick ratio of 2.47 and a debt-to-equity ratio of 0.01. The firm has a 50-day moving average price of $1.18 and a two-hundred day moving average price of $1.23. Precipio has a twelve month low of $0.91 and a twelve month high of $4.17. The company has a market capitalization of $36.34 million, a P/E ratio of -3.14 and a beta of 2.15.

Precipio (NASDAQ:PRPO - Get Rating) last posted its earnings results on Wednesday, May 11th. The biotechnology company reported ($0.20) earnings per share for the quarter. Precipio had a negative net margin of 123.12% and a negative return on equity of 46.63%. The business had revenue of $2.45 million for the quarter.

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Stock News Headlines

When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven?
Precipio Signs First IV-Cell Customer Agreement
See More Headlines

Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

PRPO Company Calendar

Last Earnings
5/11/2022
Today
8/07/2022
Next Earnings (Estimated)
8/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRPO
Employees
54
Year Founded
N/A

Profitability

Net Income
$-8,530,000.00
Net Margins
-123.12%
Pretax Margin
-122.99%

Debt

Sales & Book Value

Annual Sales
$8.85 million
Book Value
$1.08 per share

Miscellaneous

Free Float
20,779,000
Market Cap
$36.34 million
Optionable
Not Optionable
Beta
2.15














PRPO Stock - Frequently Asked Questions

How has Precipio's stock price performed in 2022?

Precipio's stock was trading at $1.58 at the beginning of 2022. Since then, PRPO stock has increased by 1.3% and is now trading at $1.60.
View the best growth stocks for 2022 here
.

Are investors shorting Precipio?

Precipio saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 128,500 shares, a decrease of 19.9% from the June 30th total of 160,500 shares. Based on an average daily volume of 213,100 shares, the days-to-cover ratio is currently 0.6 days.
View Precipio's Short Interest
.

When is Precipio's next earnings date?

Precipio is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Precipio
.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings data on Wednesday, May, 11th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2.45 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 46.63% and a negative net margin of 123.12%.

When did Precipio's stock split? How did Precipio's stock split work?

Precipio's stock reverse split on the morning of Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

What is Precipio's stock symbol?

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

Who are Precipio's major shareholders?

Precipio's stock is owned by a number of retail and institutional investors. Top institutional investors include Great Valley Advisor Group Inc. (0.15%). Company insiders that own Precipio stock include Ahmed Zaki Sabet, David Seth Cohen and Ilan Danieli.
View institutional ownership trends for Precipio
.

How do I buy shares of Precipio?

Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Precipio's stock price today?

One share of PRPO stock can currently be purchased for approximately $1.60.

How much money does Precipio make?

Precipio (NASDAQ:PRPO) has a market capitalization of $36.34 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

How many employees does Precipio have?

Precipio employs 54 workers across the globe.

How can I contact Precipio?

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for Precipio is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.

This page (NASDAQ:PRPO) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.